Thermo Fisher Scientific Inc (TMO)
571.73
-5.66
(-0.98%)
USD |
NYSE |
Apr 25, 16:00
579.51
+7.78
(+1.36%)
Pre-Market: 04:39
Thermo Fisher Scientific Free Cash Flow (Quarterly): 3.318B for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.318B |
September 30, 2023 | 2.082B |
June 30, 2023 | 1.256B |
March 31, 2023 | 271.00M |
December 31, 2022 | 2.937B |
September 30, 2022 | 1.39B |
June 30, 2022 | 1.022B |
March 31, 2022 | 1.562B |
December 31, 2021 | 1.626B |
September 30, 2021 | 2.126B |
June 30, 2021 | 1.687B |
March 31, 2021 | 1.35B |
December 31, 2020 | 2.753B |
September 30, 2020 | 2.342B |
June 30, 2020 | 1.617B |
March 31, 2020 | 103.00M |
December 31, 2019 | 1.624B |
September 30, 2019 | 901.00M |
June 30, 2019 | 1.074B |
March 31, 2019 | 448.00M |
December 31, 2018 | 1.517B |
September 30, 2018 | 1.047B |
June 30, 2018 | 1.261B |
March 31, 2018 | -40.00M |
December 31, 2017 | 1.651B |
Date | Value |
---|---|
September 30, 2017 | 817.00M |
June 30, 2017 | 761.00M |
March 31, 2017 | 268.00M |
December 31, 2016 | 1.072B |
September 30, 2016 | 723.40M |
June 30, 2016 | 798.80M |
March 31, 2016 | 219.60M |
December 31, 2015 | 1.224B |
September 30, 2015 | 642.90M |
June 30, 2015 | 669.60M |
March 31, 2015 | -17.20M |
December 31, 2014 | 797.00M |
September 30, 2014 | 585.30M |
June 30, 2014 | 813.20M |
March 31, 2014 | -3.50M |
December 31, 2013 | 634.00M |
September 30, 2013 | 449.20M |
June 30, 2013 | 412.80M |
March 31, 2013 | 232.30M |
December 31, 2012 | 555.70M |
September 30, 2012 | 403.90M |
June 30, 2012 | 442.00M |
March 31, 2012 | 322.80M |
December 31, 2011 | 556.30M |
September 30, 2011 | 297.90M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
103.00M
Minimum
Mar 2020
3.318B
Maximum
Dec 2023
1.634B
Average
1.617B
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
Fonar Corp | 3.938M |
XWELL Inc | -3.467M |
ProPhase Labs Inc | -1.523M |
Applied DNA Sciences Inc | -3.758M |
Veracyte Inc | 13.06M |